Mark Smith

Mark Smith

Company: Finch Therapeutics

Job title: CEO


Industry Leaders Panel Discussion 8:45 am

• What have been the most exciting developments within the past 12 months? • What does the path of approval and the commercialization of these products look like? • If C.difficle and consortia-based therapeutics was the low-hanging fruit, what is the next area of microbiome research? • What are the biggest challenges the field will…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.